SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven
Molecular Residual Disease study and multiple RiskScore studies among seven new datasets to be shared by Myriad and Collaborators SALT LAKE CITY, May 23, 2024 Myriad Genetics, Inc., , a leader.
Myriad Genetics Showcases New Research and Product globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Social media's allure for menopause relief masks dangers, and clinicians should know how to combat misinformation and provide education on marketed products that could put women at risk for harm.
The FDA announced it would propose a ban on formaldehyde commonly found in hair relaxers typically used by Black people and missed it's own deadline with no announcement.